Trade Name(s)ANGPT1/2(ANG1/2)
AMG 780
MEDI-3617
REGN910nesvacumab
RO5520985,RG7221
vanucizumab
B4GALNT1Ch14.18,ch14.18-UTC
dinutuximab
Unituxin BAFF belimumab
Benlysta CCR4KW-0761mogamulizum
ab
CD19MEDI-551inebilizumab
CD19/CD3MT103, MT-103, MEDI-
538blinatumomab
Blincyto GA101obinutuzumab
Gazyvaro IDEC-102,IDEC-C2B8
rituximab
Rituxan,Mabthera IDEC Y2B8ibritumomab
tiuxetan Zevalin drug can be bound via
tiuxetan to
111In or 90Y
TG-1101,
LFB-R603ublituximab
ofatumumab Arzerra,
HuMax-CD20
CD22
CAT-8015moxetumomab pasudotox CD27
CDX-1127varlilumab CD33
gemtuzumab Mylotarg CD37
TRU-016otlertuzumab daratumumab Darzalex,
HuMax-CD38
SAR650984CD52Campath alemtuzumab
ARGX-110SGN-70, h1F6vorsetuzumab
CD74hLL1milatuzumab
CD105TRC105,TRC-105, c-SN6j carotuximab
CD248(TEM1)MORAb-004
ontuxizumab
CEACAM5RG7813,RO6895882cergutuzumab
amunaleukin
CSF1R RG7155,RO5509554emactuzumab
CSF2KB003lenzilumab Therapeutic Antibodies
Target Development Name(s)Generic
Name(s)
Notes ANGPT2(ANG2)CD20CD38CD70
CP675,206
tremelimumab MDX-010,
MDX-101,
BMS-734016
ipilimumab Yervoy OMP-21M18
demcizumab OMP-305B83
navicixizumab EGFL7MEGF0444A parsatuzumab 1024 DS modotuximab ABT-806,mAb-806
depatuxizuma b ABX-EGF
panitumumab Vectibix h-R3,
TheraCIM nimotuzumab IMC-11F8
necitumumab Portrazza IMC-C225
cetuximab Erbitux MEHD7945 A
duligotuzumab MM-151
RO5083945,
GA201
imgatuzumab Sym004
futuximab FZD7OMP-18R5vantictumab GT-Mab 7.3-GEX
glycooptimized trastuzumab-GEX MGAH22
margetuximab MM-111
MOAB 2C4pertuzumab
Perjeta,Omnitarg trastuzumab Herceptin
AV 203LJM716MEHD7945 A duligotuzumab MM-111MM-121,SAR256212seribantumab MM-141istiratumab REGN1400U3-1287, AMG 888patritumab AMG 102rilotumumab AV-299,SCH900105ficlatuzumab AMG-479
ganitumab BI 836845
BIIB022
CP-751871
figitumumab IMC-A12
cixutumumab MEDI-573
dusigitumab MK-0646
dalotuzumab MM-141istiratumab
HER2(ERBB2/ne u)
HER3
(ERBB3)
HGFR
IGF-1R EGFR (HER1/ERB B1)CTLA4DLL4
BI 836845MEDI-573KIR
BMS-986015lirilumab LOXL2
AB0024, GS-6624simtuzumab ABT-700telisotuzumab LY2875358emibetuzumab MetMAb,R05490258,OA-5D onartuzumab MMP9
GS-5745andecaliximab NOTCH1
OMP-52M51brontictuzuma b NRP1
MNRP1685A vesencumab NT5E
MEDI9447oleclumab AMP-224BMS-936558,MDX-1106,ONO-4538nivolumab Opdivo CT-011pidilizumab MK-3475,lambrolizumab pembrolizuma b Keytruda MDX-1105,BMS-936559MEDI-4736durvalumab Imfinzi MPDL3280A,RG7446atezolizumab Tecentriq MSB0010718C,MSB0010682avelumab Bavencio IMC-3G3olaratumab Lartruvo MEDI-575tovetumab PIGF
ziv-aflibercept Zaltrap RANKL
denosumab Xgeva ROR1
UC-961cirmtuzumab SEMA4D
VX15/2503SLAMF7
(CS1/CD31
9/CRACC)
HuLuc63elotuzumab Empliciti TGFBR2
IMC-TR1BMS 663513urelumab PF-05082566TRAIL-
R1/DR4,R2/
D5
AMG951,rhApo2L/TRAI L dulanermin TRAIL-
R1/D4HGS-ETR1mapatumumab AMG-655conatumumab HGS-ETR2
lexatumumab LBY135
PRO95780apomab
bevacizumab Avastin
VEGFA IGF-2R
MET
PD-1
PD-L1
PDGFRα
TNFRSF9
(CD137/4-
1BB)TRAIL-
R2/D5
VEGFA
OMP-305B83navicixizumab
vanucizumab
RO5520985,
RG7221
ziv-aflibercept Zaltrap
VEGFB ziv-aflibercept Zaltrap VEGFC VGX-100
VEGFR2IMC-1121B ramucirumab Cyramza